Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The INDICATE Pilot Study (funded by the British Society for Surgery of the Hand, BSSH) is a pragmatic multicentre study to assess whether a steroid injection given initially is better than having surgery for patients with moderate carpal tunnel syndrome.

Hand   ASPC

 

BSSH

 The INDICATE Pilot Study (funded by the British Society for Surgery of the Hand, BSSH) is a pragmatic multicentre study to assess whether a steroid injection given initially is better than having surgery for patients with moderate carpal tunnel syndrome.  The pilot will inform the design and conduct of a larger INDICATE study with regards to recruitment, data collection and outcome measurement.  The Surgical Intervention Trials Unit (SITU) at the University of Oxford, will co-ordinate the trial.  This study will form part of a developing research portfolio for the plastic and hand surgery community.


Background
Carpal Tunnel Syndrome (CTS) is caused by compression of the median nerve in the wrist and presents with symptoms of tingling, numbness and pain in the hand, particularly at night. Patients usually state that the night symptoms are the most troublesome as the pain can be unremitting and sleep can be disturbed every night. CTS is the most common peripheral nerve disorder in the UK.

 

The treatment of CTS depends on its severity. Severe CTS is generally defined as presence of thenar muscle wasting and constant numbness indicating denervation. 87% of Clinical Commissioning Groups policies state that surgical decompression is warranted when these features are present.

 

Mild CTS should always be treated non-operatively while moderate CTS can be treated both non-operatively or with surgery. However there is no consensus as to the clinical distinction between mild and moderate CTS.

 

Steroid injections provide a good initial response in around 70-90% of patients with mild and moderate CTS but relapse is common. The duration of effect varies in the literature but one large recent study showed that 63% of patients had sustained effect after 6 months and this reduced to 34% after 18 months.  There is no evidence to guide treatment following relapse of a first steroid injection though if the duration of effect was reasonable, some patients prefer to have further injections and avoid surgery. The natural history of CTS has not been well studied though there is some evidence that some patients with mild CTS improve both clinically and neurophysiologically without treatment.

 

Carpal tunnel decompression (CTD) surgery is usually performed as a day case under local anaesthesia. It is 90-95% effective in permanently relieving pain, paresthesia and intermittent numbness in CTS. However it incurs more risk and recovery time for the patient and expense to the healthcare system.

 

Across England, there is variability in Clinical Commissioning Groups’ (CCG) policies for funding referral for CTS, which leads to inconsistency in treatment.  Both the variability in the CCGs’ policies and clinician’s approach to treatment stem from the paucity of good evidence on which to base treatment decisions. Therefore for patients with moderate CTS, the dilemma of whether to opt for surgery or steroid injection remains.

 

Timeline

2013                            BSSH Award

March 2014                 Surveys & Audits undertaken

September 2014         Protocol development

May 2015                    Ethics application

June 2015                   Site Set-Up

November 2015          Patient recruitment

December 2016          Pilot Follow up complete

Our team